On 25 January, we invited women, their partners, health care professionals, researchers and representatives from companies that develop medicines and authorities that approve them to join a workshop. The topic of discussion was improving how we collect information to understand the risks and benefits of medicine use in pregnancy and breastfeeding.
When discovering a potential malformation caused by drug exposure, it is important to rule out genetic causes and examine the interplay between genetics and medications. Laura Yates shared how ConcePTION is joining forces with the Decipher consortium, to utilise and adapt their existing platform for rare diseases to also include information about exposure to medicines during pregnancy. The platform will also allow for an establishment of global collaboration between clinicians to quickly highlight potential connections between drugs and genetics in these cases.
Visit the ConcePTION website [ Ссылка ]
Follow us on Twitter [ Ссылка ]
Follow us on LinkedIn [ Ссылка ]
Subscribe to our newsletter [ Ссылка ]
